FDA recall D-184-2013

Hospira Inc. · Class II · drug

Product

HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54

Reason for recall

Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2012-10-22
Report date
2013-03-13
Termination date
2015-03-31
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-184-2013